Share ownership Lotus Pharmaceutical Co., Ltd.

1795

TW0001795003

Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 2025-06-20			5-day change	1st Jan Change
216.00 ^TWD	0.00%		-1.14%	-19.85%

06-19	Lotus Pharmaceutical Unit to Acquire Product Rights in Vietnam for $15.5 Million	MT
06-09	Tranche Update on Lotus Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on April 10, 2025.	CI

Share class: Lotus Pharmaceutical Co., Ltd.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	265,858,312	154,325,312 ( 58.05 %)	464,000 ( 0.1745 %)	58.05 %

Major shareholders: Lotus Pharmaceutical Co., Ltd.

Name	Equities	%	Valuation
Celtic Holdings SCA 40.99 %	108,968,519	40.99 %	853 M NT$
State Street Global Advisors Ltd. 0.1087 %	289,000	0.1087 %	2 M NT$
Franklin Templeton SinoAm Securities Investment Mgmt, Inc 0.0734 %	195,000	0.0734 %	2 M NT$
JOHCM (Singapore) Pte Ltd. 0.0275 %	73,000	0.0275 %	571 216 NT$
Union Securities Investment Trust Co., Ltd. 0.0263 %	70,000	0.0263 %	547 742 NT$
Atlantis Investment Management Ltd. /Hong Kong/ 0.001881 %	5,000	0.001881 %	39 124 NT$
State Street Global Advisors Europe Ltd. 0.001881 %	5,000	0.001881 %	39 124 NT$
SinoPac Securities Investment Trust Co., Ltd. 0.000272 %	722	0.000272 %	5 650 NT$

Breakdown by shareholder type

Other	40.99%
Institutional	0.24%
Unknown	58.77%

Based on 1000 largest holdings

Geographical origin of shareholders

Luxembourg	40.99%
United Kingdom	0.11%
Taiwan	0.1%
Singapore	0.03%

Based on 1000 largest holdings

Lotus Pharmaceutical Co Ltd is a Taiwan-based company mainly engaged in the manufacture and sale of generic drugs. The products are mainly solid preparations such as tablets and capsules. The main products include oral anti-cancer drugs, cardiovascular disease drugs, central nervous system drugs, women's health products, osteoporosis drugs and mental disease drugs. The Company is also engaged in the drug research, development and clinical testing business, as well as the product licensing business. The Company mainly distributes products in Taiwan, South Korea, the United States, China mainland, Japan, Europe and Southeast Asia markets.

Employees

1,099

Sector

Pharmaceuticals

Calendar

06-25 - Annual General Meeting

More about the company